Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Speller, Jeremy C.
Barnes, Thomas R. E.
Curson, David A.
Pantelis, Christos
and
Alberts, J. L.
1997.
One-year, low-dose neuroleptic study of in-patients with chronic schizophrenia characterised by persistent negative symptoms.
British Journal of Psychiatry,
Vol. 171,
Issue. 6,
p.
564.
Lecrubier, Y
Boyer, P
Turjanski, S
and
Rein, W
1997.
Amisulpride versus imipramine and placebo in dysthymia and major depression.
Journal of Affective Disorders,
Vol. 43,
Issue. 2,
p.
95.
Reid, S.
and
Turner, J.
1998.
Amisulpride in schizophrenia.
British Journal of Psychiatry,
Vol. 172,
Issue. 5,
p.
450.
Langer, Salomon Z
Scatton, B
Schoemaker, H
and
Rein, W
1998.
Langer et al. reply.
Trends in Pharmacological Sciences,
Vol. 19,
Issue. 4,
p.
128.
Martin, Stephen
1998.
Schizophrenia: Drug Therapy.
Practice Nursing,
Vol. 9,
Issue. 16,
p.
34.
Puech, A.
Fleurot, O.
and
Rein, W.
1998.
Amisulpride, an atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose‐ranging study vs. haloperidol.
Acta Psychiatrica Scandinavica,
Vol. 98,
Issue. 1,
p.
65.
King, David J.
1998.
Atypical antipsychotics and the negative symptoms of schizophrenia.
Advances in Psychiatric Treatment,
Vol. 4,
Issue. 1,
p.
53.
Möller, H.-J.
1998.
Schizophrenie — Moderne Konzepte zu Diagnostik, Pathogenese und Therapie.
p.
207.
Laduron, Pierre M
1998.
Presynaptic receptors: more hetero than auto.
Trends in Pharmacological Sciences,
Vol. 19,
Issue. 4,
p.
127.
Möller, H.-J.
1999.
Atypische Neuroleptika.
p.
25.
Barnes, Thomas R. E.
and
McPhillips, Mike A.
1999.
Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics*.
British Journal of Psychiatry,
Vol. 174,
Issue. S38,
p.
34.
Hoes, M.J.A.J.M.
1999.
Recent antipsychotics in the treatment of psychoses.
Acta Neuropsychiatrica,
Vol. 11,
Issue. 3,
p.
85.
Blin, Olivier
1999.
A Comparative Review of New Antipsychotics.
The Canadian Journal of Psychiatry,
Vol. 44,
Issue. 3,
p.
235.
Patat, Alain
Rosenzweig, Pierre
Miget, Nathalie
Allain, Hervé
and
Gandon, Jean‐Marc
1999.
Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep‐deprived subjects.
Fundamental & Clinical Pharmacology,
Vol. 13,
Issue. 5,
p.
582.
Carvajal, Alfonso
and
Martín Arias, Luis H.
1999.
Vol. 22,
Issue. ,
p.
45.
Naber, D.
and
Lambert, M.
1999.
Atypische Neuroleptika.
p.
1.
Fleischhacker, W. W.
1999.
Search for the Causes of Schizophrenia.
p.
331.
Peuskens, Joseph
Bech, Per
Möller, Hans-Jürgen
Bale, Robert
Fleurot, Odile
and
Rein, Werner
1999.
Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia.
Psychiatry Research,
Vol. 88,
Issue. 2,
p.
107.
Danion, Jean-Marie
Rein, Werner
Fleurot, Odile
and
the Amisulpride Study Group
1999.
Improvement of Schizophrenic Patients With Primary Negative Symptoms Treated With Amisulpride.
American Journal of Psychiatry,
Vol. 156,
Issue. 4,
p.
610.
Möller, Hans-Jürgen
2000.
State of the Art of Drug Treatment of Schizophrenia and the Future Position of the Novel/Atypical Antipsychotics.
The World Journal of Biological Psychiatry,
Vol. 1,
Issue. 4,
p.
204.
eLetters
No eLetters have been published for this article.